Kamada Reaches New 52-Week Low at $6.98 (KMDA)
Kamada (NASDAQ:KMDA) hit a new 52-week low on Monday , Stock Ratings Network reports. The stock traded as low as $6.98 and last traded at $7.16, with a volume of 37,167 shares trading hands. The stock had previously closed at $7.00.
KMDA has been the subject of a number of recent research reports. Analysts at Oppenheimer downgraded shares of Kamada from an “outperform” rating to a “market perform” rating in a research note on Friday, May 16th. Analysts at Zacks downgraded shares of Kamada from a “neutral” rating to an “underperform” rating in a research note on Monday, May 12th. They now have a $12.70 price target on the stock.
The stock has a 50-day moving average of $8.55 and a 200-day moving average of $13.60. The company’s market cap is $247.3 million.
Kamada (NASDAQ:KMDA) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.06. The company had revenue of $13.20 million for the quarter, compared to the consensus estimate of $15.97 million. On average, analysts predict that Kamada will post $0.02 earnings per share for the current fiscal year.
Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.